"Mice, Transgenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
Descriptor ID |
D008822
|
MeSH Number(s) |
B01.050.050.136.500 B01.050.150.900.649.313.992.635.505.500.800
|
Concept/Terms |
Mice, Transgenic- Mice, Transgenic
- Mouse, Transgenic
- Transgenic Mouse
- Transgenic Mice
Founder Mice, Transgenic- Founder Mice, Transgenic
- Mice, Transgenic Founder
- Transgenic Founder Mice
- Mouse, Founder, Transgenic
|
Below are MeSH descriptors whose meaning is more general than "Mice, Transgenic".
Below are MeSH descriptors whose meaning is more specific than "Mice, Transgenic".
This graph shows the total number of publications written about "Mice, Transgenic" by people in this website by year, and whether "Mice, Transgenic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 4 | 4 |
1995 | 0 | 5 | 5 |
1996 | 0 | 9 | 9 |
1997 | 1 | 11 | 12 |
1998 | 0 | 7 | 7 |
1999 | 0 | 6 | 6 |
2000 | 0 | 12 | 12 |
2001 | 0 | 11 | 11 |
2002 | 3 | 16 | 19 |
2003 | 0 | 28 | 28 |
2004 | 0 | 28 | 28 |
2005 | 1 | 30 | 31 |
2006 | 0 | 40 | 40 |
2007 | 0 | 25 | 25 |
2008 | 0 | 39 | 39 |
2009 | 0 | 39 | 39 |
2010 | 0 | 39 | 39 |
2011 | 0 | 41 | 41 |
2012 | 0 | 33 | 33 |
2013 | 0 | 39 | 39 |
2014 | 0 | 46 | 46 |
2015 | 0 | 37 | 37 |
2016 | 0 | 26 | 26 |
2017 | 0 | 34 | 34 |
2018 | 0 | 27 | 27 |
2019 | 0 | 20 | 20 |
2020 | 1 | 15 | 16 |
2021 | 0 | 12 | 12 |
2022 | 0 | 5 | 5 |
2023 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mice, Transgenic" by people in Profiles.
-
Generating a Murine PTEN Null Cell Line to Discover the Key Role of p110?-PAK1 in Castration-Resistant Prostate Cancer Invasion. Mol Cancer Res. 2023 12 01; 21(12):1317-1328.
-
A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studies. Biochem Pharmacol. 2023 04; 210:115470.
-
Defects in placental syncytiotrophoblast cells are a common cause of developmental heart disease. Nat Commun. 2023 03 01; 14(1):1174.
-
Epigenetic function during heroin self-administration controls future relapse-associated behavior in a cell type-specific manner. Proc Natl Acad Sci U S A. 2023 02 14; 120(7):e2210953120.
-
Brain microstructure abnormalities in the 3xTg-AD mouse - A diffusion MRI and morphology correlation study. Magn Reson Imaging. 2022 12; 94:48-55.
-
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders. Pharmacol Rev. 2022 07; 74(3):600-629.
-
NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons. FASEB J. 2022 04; 36(4):e22262.
-
Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression. Viruses. 2022 03 05; 14(3).
-
Suppression of Fli-1 protects against pericyte loss and cognitive deficits in Alzheimer's disease. Mol Ther. 2022 04 06; 30(4):1451-1464.
-
Distinct features of brain perivascular fibroblasts and mural cells revealed by in vivo two-photon imaging. J Cereb Blood Flow Metab. 2022 06; 42(6):966-978.